Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review
Tiago Costa de Pádua, Marco Moschini, Alberto Martini, Filippo Pederzoli, Luigi Nocera, Laura Marandino, Daniele Raggi, Alberto Briganti, Francesco Montorsi, Andrea Necchi
Topics & Concepts
MedicinePembrolizumabMetastatic Urothelial CarcinomaOncologyInternal medicineBladder cancerAdverse effectClinical trialAntibody-drug conjugateCancerCisplatinPhases of clinical researchChemotherapyAntibodyMonoclonal antibodyImmunotherapyImmunologyUrothelial carcinomaBladder and Urothelial Cancer TreatmentsAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer Research